(April 6, 2016, 11:22 AM EDT) -- NEW YORK — Pfizer Inc. on April 6 said it and Allergan PLC have agreed to terminate their November merger agreement “as a result of the occurrence of an adverse tax law change,” according to a Form 8-K filed with the U.S. Securities and Exchange Commission....